Pietro Arina

Dr. Pietro Arina

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2023 in Anesthesiology
Verified
Journal Article
Open access
PDF file
PAPietro Arina
Pietro Arina
MKMaciej R. Kaczorek
Maciej R. Kaczorek
DHDaniel A. Hofmaenner
Daniel A. Hofmaenner
WPWalter Pisciotta
Walter Pisciotta
PRPatricia Refinetti
Patricia Refinetti
JWJohn Whittle
John Whittle
Background: The utilization of artificial intelligence and machine learning as diagnostic and predictive tools in perioperative medicine holds great promise. Indeed, many studies have been performed in recent years to explore the potential. The purpose of this systematic review is to assess the current state of machine learning in perioperative medicine, its utility in prediction of complications and prognostication, and limitations related to bias and validation. Methods: A multidisciplinary team of clinicians and engineers conducted a systematic review using the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) protocol. Multiple databases were searched, including Scopus, Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Cochrane Library, PubMed, Medline, Embase, and Web of Science. The systematic review focused on study design, type of machine learning model used, validation techniques applied, and reported model performance on prediction of complications and prognostication. This review further classified outcomes and machine learning applications using an ad hoc classification system. The Prediction model Risk Of Bias Assessment Tool (PROBAST) was used to assess risk of bias and applicability of the studies. Results: A total of 103 studies were identified. The models reported in the literature were primarily based on single-center validations (75%), with only 13% being externally validated across multiple centers. Most of the mortality models demonstrated a limited ability to discriminate and classify effectively. The PROBAST assessment indicated a high risk of systematic errors in predicted outcomes and artificial intelligence or machine learning applications. Conclusions: The findings indicate that the development of this field is still in its early stages. This systematic review indicates that application of machine learning in perioperative medicine is still at an early stage. While many studies suggest potential utility, several key challenges must be first overcome before their introduction into clinical practice. Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New:

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Tapan Kumar MohantaTapan Kumar Mohanta
Tapan Kumar Mohanta
NSNanaocha Sharma
Nanaocha Sharma
PAPietro Arina
Pietro Arina
PDPaola Defilippi
Paola Defilippi
The mitogen‐activated protein kinase (MAPK) pathway links the cell‐surface receptors to the transcription machinery, transducing the extracellular signals into several outputs, which may also adapt the host defense mechanism to viral attacks. The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS‐CoV‐2) that causes the COrona VIrus Disease 2019 (COVID‐19) has infected upwards of nearly 70 million people and worldwide has claimed more than 1,600,000 deaths. So far, there continues to be no specific treatment for this novel coronavirus‐induced disease. In the search to control the global COVID‐19 pandemic, some eastern and developing countries have approved a variety of treatments with controversial efficacy, among which is the use of the antimalarial hydroxychloroquine (HCQ). Interestingly, prior data had indicated that the HCQ/CQ could influence the MAPK cascade. The main aim of this review is to address molecular mechanisms, beyond drugs, that can be helpful against viral infection for this and future pandemics. We will highlight (1) the contribution of the MAPK cascade in viral infection and (2) the possible use of MAPK inhibitors in curbing viral infections, alone or in combination with HCQ and quinoline analogues. We are convinced that understanding the molecular patterns of viral infections will be critical for new therapeutical approaches to control this and other severe diseases.

16 October 2024 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
DFDavide Ferrari
Davide Ferrari
PAPietro Arina
Pietro Arina
JEJonathan Edgeworth
Jonathan Edgeworth
VCVasa Curcin
Vasa Curcin
VGVeronica Guidetti
Veronica Guidetti
YWYanzhong Wang
Yanzhong Wang
Nosocomial infections and Antimicrobial Resistance (AMR) stand as formidable healthcare challenges on a global scale. To address these issues, various infection control protocols and personalized treatment strategies, guided by laboratory tests, aim to detect bloodstream infections (BSI) and assess the potential for AMR. In this study, we introduce a machine learning (ML) approach based on Multi-Objective Symbolic Regression (MOSR), an evolutionary approach to create ML models in the form of readable mathematical equations in a multi-objective way to overcome the limitation of standard single-objective approaches. This method leverages readily available clinical data collected upon admission to intensive care units, with the goal of predicting the presence of BSI and AMR. We further assess its performance by comparing it to established ML algorithms using both naturally imbalanced real-world data and data that has been balanced through oversampling techniques. Our findings reveal that traditional ML models exhibit subpar performance across all training scenarios. In contrast, MOSR, specifically configured to minimize false negatives by optimizing also for the F1-Score, outperforms other ML algorithms and consistently delivers reliable results, irrespective of the training set balance with F1-Score.22 and.28 higher than any other alternative. This research signifies a promising path forward in enhancing Antimicrobial Stewardship (AMS) strategies. Notably, the MOSR approach can be readily implemented on a large scale, offering a new ML tool to find solutions to these critical healthcare issues affected by limited data availability.

2 February 2024 in British Journal of Anaesthesia
Verified
Journal Article
Open access
WPWalter Pisciotta
Walter Pisciotta
APAlberto Passannante
Alberto Passannante
PAPietro Arina
Pietro Arina
KAKhalid Alotaibi
Khalid Alotaibi
GAGareth Ambler
Gareth Ambler
NANishkantha Arulkumaran
Nishkantha Arulkumaran
Noninvasive methods of respiratory support, including noninvasive ventilation (NIV), continuous positive airway pressure (CPAP), and high-flow nasal oxygen (HFNO), are potential strategies to prevent progression to requirement for invasive mechanical ventilation in acute hypoxaemic respiratory failure. The COVID-19 pandemic provided an opportunity to understand the utility of noninvasive respiratory support among a homogeneous cohort of patients with contemporary management of acute respiratory distress syndrome. We performed a network meta-analysis of studies evaluating the efficacy of NIV (including CPAP) and HFNO, compared with conventional oxygen therapy (COT), in patients with COVID-19. PubMed, Embase, and the Cochrane library were searched in May 2023. Standard random-effects meta-analysis was used first to estimate all direct pairwise associations and the results from all studies were combined using frequentist network meta-analysis. Primary outcome was treatment failure, defined as discontinuation of HFNO, NIV, or COT despite progressive disease. Secondary outcome was mortality. We included data from eight RCTs with 2302 patients, (756 [33%] assigned to COT, 371 [16%] to NIV, and 1175 [51%] to HFNO). The odds of treatment failure were similar for NIV (P=0.33) and HFNO (P=0.25), and both were similar to that for COT (reference category). The odds of mortality were similar for all three treatments (odds ratio for NIV vs COT: 1.06 [0.46-2.44] and HFNO vs COT: 0.97 [0.57-1.65]). Noninvasive ventilation, high-flow nasal oxygen, and conventional oxygen therapy are comparable with regards to treatment failure and mortality in COVID-19-associated acute respiratory failure. CRD42023426495.

20 December 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
GCGiorgia Centonze
Giorgia Centonze
DNDora Natalini
Dora Natalini
SGSilvia Grasso
Silvia Grasso
AMAlessandro Morellato
Alessandro Morellato
VSVincenzo Salemme
Vincenzo Salemme
Paola DefilippiPaola Defilippi
Paola Defilippi
P140Cap is an adaptor protein involved in assembling multi-protein complexes regulating several cellular processes. p140Cap acts as a tumor suppressor in breast cancer (BC) and neuroblastoma patients, where its expression correlates with a better prognosis. The role of p140Cap in tumor metabolism remains largely unknown. Here we study the role of p140Cap in the modulation of the mevalonate (MVA) pathway in BC cells. The MVA pathway is responsible for the biosynthesis of cholesterol and non-sterol isoprenoids and is often deregulated in cancer. We found that both in vitro and in vivo, p140Cap cells and tumors show an increased flux through the MVA pathway by positively regulating the pace-maker enzyme of the MVA pathway, the 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR), via transcriptional and post-translational mechanisms. The higher cholesterol synthesis is paralleled with enhanced cholesterol efflux. Moreover, p140Cap promotes increased cholesterol localization in the plasma membrane and reduces lipid rafts-associated Rac1 signalling, impairing cell membrane fluidity and cell migration in a cholesterol-dependent manner. Finally, p140Cap BC cells exhibit decreased cell viability upon treatments with statins, alone or in combination with chemotherapeutic at low concentrations in a synergistic manner. Overall, our data highlight a new perspective point on tumor suppression in BC by establishing a previously uncharacterized role of the MVA pathway in p140Cap expressing tumors, thus paving the way to the use of p140Cap as a potent biomarker to stratify patients for better tuning therapeutic options.

8 January 2025 in Anaesthesia
Verified
Journal Article
Open access
PAPietro Arina
Pietro Arina
DFDavide Ferrari
Davide Ferrari
NTNicholas Tetlow
Nicholas Tetlow
ADAmy Dewar
Amy Dewar
RSRobert Stephens
Robert Stephens
EMEvangelos B. Mazomenos
Evangelos B. Mazomenos
Summary: Introduction: Understanding 1‐year mortality following major surgery offers valuable insights into patient outcomes and the quality of peri‐operative care. Few models exist that predict 1‐year mortality accurately. This study aimed to develop a predictive model for 1‐year mortality in patients undergoing complex non‐cardiac surgery using a novel machine‐learning technique called multi‐objective symbolic regression. Methods: A single‐institution database of patients undergoing major elective surgery with previous cardiopulmonary exercise testing was divided into three datasets: pre‐operative clinical data; cardiorespiratory and physiological data; and combined. A multi‐objective symbolic regression model was developed and compared against existing models. Model performance was evaluated using the F1 score. Shapley additive explanations analysis was used to identify the major contributors to model performance. Results: From 2145 patients in the database, 1190 were included, with 952 in the training dataset and 238 in the test dataset. Median (IQR [range]) age was 71 (61–79 [45–89]) years and 825 (69%) were male. The multi‐objective symbolic regression model demonstrated robust consistency with an F1 score of 0.712. Shapley additive explanations analysis indicated that ventilatory equivalents for carbon dioxide, oxygen at peak exercise and BMI influenced model performance most significantly, surpassing surgery type and named comorbidities. Discussion: This study confirms the feasibility of developing a multi‐objective symbolic regression‐based model for predicting 1‐year postoperative mortality in a mixed non‐cardiac surgical population. The model's strong performance underscores the critical role of physiological data, particularly cardiorespiratory fitness, in surgical risk assessment and emphasises the importance of pre‐operative optimisation to identify and manage high‐risk patients. The multi‐objective symbolic regression model demonstrated high sensitivity and a good F1 score, highlighting its potential as an effective tool for peri‐operative risk prediction.